Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2023-10-13 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年10月法人說明會簡報 — 179520230815E002.pdf
Investor Presentation Classification · 95% confidence The document is titled '2023 Q2 EARNINGS RESULTS Investor Presentation' and contains detailed financial results for the second quarter of 2023, including revenue, net income, EPS, segment performance, and business highlights. It includes forward-looking statements, business development updates, pipeline execution, and financial highlights with actual financial data. The content is structured as a presentation aimed at investors, focusing on financials, strategy, and market position. It is not a full annual or interim report, nor is it a transcript or regulatory filing. The presence of slides, business highlights, and financial results aligns with the definition of an Investor Presentation (IP). The document length (15,000 characters) and detailed financial data support this classification with high confidence.
2023-10-13 Chinese
112年10月法人說明會簡報 — 179520230815M002.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2023 Q2 Operational Results Report" and is described as an "Investor Report". It contains detailed financial results for the second quarter of 2023, including revenue, gross profit, net profit, and EPS figures, as well as operational highlights, product development progress, market expansion, and licensing agreements. The content is comprehensive and includes substantive financial data and analysis for a quarterly period. There is no indication that this is merely an announcement or a presentation without financial statements. The document length is substantial (15,000 characters), supporting that it is a full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q2 2023
2023-10-13 Chinese
112年10月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a schedule and summary of an investor presentation event, specifically a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. It includes details such as company code, company name, date, time, location, and a brief description of the event. There is no financial data or report attached, only references to presentation materials and links. The document is short (794 characters) and serves as an announcement or summary of the investor presentation event rather than the presentation itself or a financial report. Therefore, the most appropriate classification is 'Investor Presentation' (IP).
2023-10-13 Chinese
公告本公司品質管理副總經理異動
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's senior management, specifically the resignation of the Vice President of Quality Management and the appointment of a new person to that role. It includes details such as names, titles, dates, and reasons for the change. There is no financial data, report, or presentation content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-10-11 Chinese
112年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (美時) providing details on fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is a regulatory financial update related to credit and guarantee exposures, but it does not contain comprehensive financial statements or detailed analysis typical of annual or interim reports. The document length is short (621 characters), and it primarily reports specific financial data points without broader context or narrative. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial information that does not fit into more specific categories like Annual Report, Interim Report, or Capital Update.
2023-10-11 Chinese
112年9月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized financial data report showing monthly and cumulative net operating revenue figures for a company named 美時 for the period 民國112年09月 (September 2023). It includes percentage changes compared to the previous year and explanations for revenue changes. The document is very short (838 characters) and contains no detailed financial statements or comprehensive analysis. It appears to be a brief financial summary or factsheet rather than a full report or announcement of a report. There is no indication of it being an earnings release, annual or interim report, or any regulatory filing. Given the concise nature and focus on key financial figures, the best fitting category is Fund Information / Factsheet (FS).
2023-10-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.